Trial
NCT04311489
Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Aarhus
Collaborators
Aarhus University Hospital; ADS AIPHIA Development Services AG
Condition
Cirrhosis, Liver
Intervention
Ularitide
Why stopped
Interim analysis showing safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-18